143 related articles for article (PubMed ID: 20605499)
1. Contribution of serum inflammatory markers to changes in bone mineral content and density in postmenopausal women: a 1-year investigation.
Gertz ER; Silverman NE; Wise KS; Hanson KB; Alekel DL; Stewart JW; Perry CD; Bhupathiraju SN; Kohut ML; Van Loan MD
J Clin Densitom; 2010; 13(3):277-82. PubMed ID: 20605499
[TBL] [Abstract][Full Text] [Related]
2. The soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.
Alekel DL; Van Loan MD; Koehler KJ; Hanson LN; Stewart JW; Hanson KB; Kurzer MS; Peterson CT
Am J Clin Nutr; 2010 Jan; 91(1):218-30. PubMed ID: 19906801
[TBL] [Abstract][Full Text] [Related]
3. Soy protein consumption and bone mass in early postmenopausal Chinese women.
Ho SC; Woo J; Lam S; Chen Y; Sham A; Lau J
Osteoporos Int; 2003 Oct; 14(10):835-42. PubMed ID: 12920508
[TBL] [Abstract][Full Text] [Related]
4. One year soy protein supplementation has positive effects on bone formation markers but not bone density in postmenopausal women.
Arjmandi BH; Lucas EA; Khalil DA; Devareddy L; Smith BJ; McDonald J; Arquitt AB; Payton ME; Mason C
Nutr J; 2005 Feb; 4():8. PubMed ID: 15727682
[TBL] [Abstract][Full Text] [Related]
5. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
6. Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study.
Ding C; Parameswaran V; Udayan R; Burgess J; Jones G
J Clin Endocrinol Metab; 2008 May; 93(5):1952-8. PubMed ID: 18285417
[TBL] [Abstract][Full Text] [Related]
7. Apparent bone mineral density estimated from DXA in healthy men and women.
Cvijetić S; Korsić M
Osteoporos Int; 2004 Apr; 15(4):295-300. PubMed ID: 14628108
[TBL] [Abstract][Full Text] [Related]
8. Soymilk or progesterone for prevention of bone loss--a 2 year randomized, placebo-controlled trial.
Lydeking-Olsen E; Beck-Jensen JE; Setchell KD; Holm-Jensen T
Eur J Nutr; 2004 Aug; 43(4):246-57. PubMed ID: 15309425
[TBL] [Abstract][Full Text] [Related]
9. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.
Alekel DL; Germain AS; Peterson CT; Hanson KB; Stewart JW; Toda T
Am J Clin Nutr; 2000 Sep; 72(3):844-52. PubMed ID: 10966908
[TBL] [Abstract][Full Text] [Related]
10. Associations Between Inflammatory Mediators and Bone Outcomes in Postmenopausal Women: A Cross-Sectional Analysis of Baseline Data from the Prune Study.
Damani JJ; De Souza MJ; Strock NCA; Koltun KJ; Williams NI; Weaver C; Rogers CJ
J Inflamm Res; 2023; 16():639-663. PubMed ID: 36814438
[TBL] [Abstract][Full Text] [Related]
11. The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial.
Marcus R; Holloway L; Wells B; Greendale G; James MK; Wasilauskas C; Kelaghan J
J Bone Miner Res; 1999 Sep; 14(9):1583-95. PubMed ID: 10469288
[TBL] [Abstract][Full Text] [Related]
12. Association between lumbar bone mineral density and serum uric acid in postmenopausal women: a cross-sectional study of healthy Chinese population.
Han W; Bai X; Wang N; Han L; Sun X; Chen X
Arch Osteoporos; 2017 Dec; 12(1):50. PubMed ID: 28527105
[TBL] [Abstract][Full Text] [Related]
13. Association between inflammatory biomarkers and bone mineral density in a community-based cohort of men and women.
Sponholtz TR; Zhang X; Fontes JD; Meigs JB; Cupples LA; Kiel DP; Hannan MT; McLean RR
Arthritis Care Res (Hoboken); 2014 Aug; 66(8):1233-40. PubMed ID: 24375982
[TBL] [Abstract][Full Text] [Related]
14. The levels of bone turnover markers 25(OH)D and PTH and their relationship with bone mineral density in postmenopausal women in a suburban district in China.
Gao C; Qiao J; Li SS; Yu WJ; He JW; Fu WZ; Zhang ZL
Osteoporos Int; 2017 Jan; 28(1):211-218. PubMed ID: 27468899
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
Uretmen S; Gol M; Cimrin D; Irmak E
Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
[TBL] [Abstract][Full Text] [Related]
16. Associations among endocrine, inflammatory, and bone markers, body composition and weight loss induced bone loss.
Labouesse MA; Gertz ER; Piccolo BD; Souza EC; Schuster GU; Witbracht MG; Woodhouse LR; Adams SH; Keim NL; Van Loan MD
Bone; 2014 Jul; 64():138-46. PubMed ID: 24709689
[TBL] [Abstract][Full Text] [Related]
17. Concomitant increase in muscle strength and bone mineral density with decreasing IL-6 levels after combination therapy with alendronate and calcitriol in postmenopausal women.
Park JH; Park KH; Cho S; Choi YS; Seo SK; Lee BS; Park HS
Menopause; 2013 Jul; 20(7):747-53. PubMed ID: 23511701
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Dried Beancurd on Bone Mineral Density in Postmenopausal Chinese Women: A 2-Year Randomized Controlled Trial.
Li L; Sun M; Sun J; Kong H; Zhong W; Wang H
Calcif Tissue Int; 2019 Dec; 105(6):573-581. PubMed ID: 31489467
[TBL] [Abstract][Full Text] [Related]
19. Cytokine production and bone mineral density at the lumbar spine and femoral neck in premenopausal women.
Salamone LM; Whiteside T; Friberg D; Epstein RS; Kuller LH; Cauley JA
Calcif Tissue Int; 1998 Dec; 63(6):466-70. PubMed ID: 9817939
[TBL] [Abstract][Full Text] [Related]
20. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
